A 58-year-old man with chronic atrial fibrillation is being evaluated for antiarrhythmic therapy. His echocardiogram shows normal left ventricular ejection fraction (LVEF 55%). Which feature best distinguishes Class IC antiarrhythmics (flecainide, propafenone) from Class II antiarrhythmics (beta-blockers) in this patient's management?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.